Breast cancer tumors with high Ki-67 (>20%) have been associated with a higher probability of disease relapse (79.1% versus 55.3%) and death (95.6% versus 71%) within four years, when compared to tumors with low Ki-67 values [54]. This evidence concerns the gene MKI67 and breast carcinoma.